Illumina Inc. rose as much as 8 percent to its highest level since December after a report that Thermo Fisher Scientific Inc. made a $30 billion offer for the rival maker of gene-sequencing equipment.
SUBSCRIBE
Biohealth Innovation
Founding Member of
